$SBIG
springbig Holdings Inc Stock $sbig

$sbig Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024023235 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$6.612M	$6.474M
YoY Change	-8.34%	-9.54%
Cost Of Revenue	$1.915M	$1.794M
YoY Change	26.74%	32.89%
Gross Profit	$4.697M	$4.680M
YoY Change	-17.64%	-19.41%
Gross Profit Margin	71.04%	72.29%
Selling, General & Admin	$3.484M	$3.296M
YoY Change	-35.85%	-37.04%
% of Gross Profit	74.18%	70.43%
Research & Development	$1.270M	$1.666M
YoY Change	-37.9%	-27.57%
% of Gross Profit	27.04%	35.6%
Depreciation & Amortization		$54.00K
YoY Change		-18.18%
% of Gross Profit		1.15%
Operating Expenses	$4.754M	$4.962M
YoY Change	-36.41%	-34.15%
Operating Profit	-$57.00K	-$282.0K
YoY Change	-96.79%	-83.68%
Interest Expense	$544.0K	-$871.0K
YoY Change	-270.0%	128.61%
% of Operating Profit
Other Income/Expense, Net		-$3.000K
YoY Change		-98.04%
Pretax Income	-$647.0K	$417.0K
YoY Change	-68.13%	-118.44%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	-$647.0K	$417.0K
YoY Change	-68.1%	-118.44%
Net Earnings / Revenue	-9.79%	6.44%
Basic Earnings Per Share	-$0.01	$0.01
Diluted Earnings Per Share	-$0.01	$0.01
COMMON SHARES
Basic Shares Outstanding	45.59M shares	45.59M shares
Diluted Shares Outstanding	45.72M shares	77.32M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.668M
YoY Change		-35.07%
Cash & Equivalents	$700.0K	$1.700M
Short-Term Investments
Other Short-Term Assets		$588.0K
YoY Change		-42.69%
Inventory
Prepaid Expenses
Receivables	$3.223M	$3.211M
Other Receivables		$0.00
Total Short-Term Assets	$4.724M	$5.722M
YoY Change	-28.56%	-19.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$282.0K	$325.0K
YoY Change	-14.02%	2.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.223M	$3.356M
YoY Change	163.53%	178.04%
TOTAL ASSETS
Total Short-Term Assets	$4.724M	$5.722M
Total Long-Term Assets	$3.223M	$3.356M
Total Assets	$7.947M	$9.078M
YoY Change	1.42%	9.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.602M	$2.040M
YoY Change	-35.06%	12.09%
Accrued Expenses		$2.445M
YoY Change		-14.75%
Deferred Revenue	$1.751M	$2.000K
YoY Change	714.42%	-99.24%
Short-Term Debt	$510.0K	$0.00
YoY Change
Long-Term Debt Due	$7.391M	$0.00
YoY Change	320.9%	-100.0%
Total Short-Term Liabilities		$7.084M
YoY Change		-39.81%
LONG-TERM LIABILITIES
Long-Term Debt	$13.64M	$7.198M
YoY Change	381.84%	409.05%
Other Long-Term Liabilities		$2.821M
YoY Change		289.64%
Total Long-Term Liabilities	$13.64M	$7.198M
YoY Change	287.39%	236.67%
TOTAL LIABILITIES
Total Short-Term Liabilities		$7.084M
Total Long-Term Liabilities	$13.64M	$7.198M
Total Liabilities	$16.42M	$17.10M
YoY Change	43.04%	22.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.80M	-$36.10M
YoY Change	20.26%	26.22%
Common Stock	$4.000K	$4.000K
YoY Change	0.0%	33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.472M	-$8.025M
YoY Change
Total Liabilities & Shareholders Equity	$7.947M	$9.078M
YoY Change	1.42%	9.47%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$647.0K	$417.0K
YoY Change	-68.1%	-118.44%
Depreciation, Depletion And Amortization		$54.00K
YoY Change		-18.18%
Cash From Operating Activities		-$1.900M
YoY Change		-575.0%
INVESTING ACTIVITIES
Capital Expenditures		$59.00K
YoY Change		555.56%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities		-$59.00K
YoY Change		391.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$3.274M
YoY Change		-343.6%
NET CHANGE
Cash From Operating Activities		-$1.900M
Cash From Investing Activities		-$59.00K
Cash From Financing Activities		$3.274M
Net Change In Cash		$1.315M
YoY Change		-237.55%
FREE CASH FLOW
Cash From Operating Activities		-$1.900M
Capital Expenditures		$59.00K
Free Cash Flow		-$1.959M
YoY Change		-601.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40049
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	SPRINGBIG HOLDINGS, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton,
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	225000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	13779000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001801602
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-2789488
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45594864	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1668000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	331000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2948000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	255000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	273000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	588000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	893000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	5722000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4445000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	340000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	325000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	329000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7084000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2815000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45339762	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45339762	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28119000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36148000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36565000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-8025000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8674000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9078000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5105000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6474000	usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y89M27D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y17M27D
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	621 NW 53rd Street
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 500
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33487
CY2024Q1	dei	City Area Code CityAreaCode	800
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	772-9172
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3211000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3031000	usd
CY2024Q1	us-gaap	Assets Assets	9078000	usd
CY2023Q4	us-gaap	Assets Assets	5105000	usd
CY2024Q1	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	1767000	usd
CY2023Q4	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	1951000	usd
CY2024Q1	wdq	Accounts Payable Cash Advance Current AccountsPayableCashAdvanceCurrent	1195000	usd
CY2023Q4	wdq	Accounts Payable Cash Advance Current AccountsPayableCashAdvanceCurrent	1925000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4360000	usd
CY2024Q1	wdq	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	1751000	usd
CY2023Q4	wdq	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	1751000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	329000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	99000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13551000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7198000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2815000	usd
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	17103000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45594864	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45594864	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27887000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7157000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	1794000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1350000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	4680000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	5807000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1527000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2478000	usd
CY2024Q1	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	1666000	usd
CY2023Q1	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	2300000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1769000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2757000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	4962000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	7535000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-282000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1728000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	10000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	875000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	391000	usd
CY2024Q1	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	1573000	usd
CY2023Q1	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	0	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-153000	usd
CY2024Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	417000	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2262000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	417000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2262000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45432272	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26803839	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77315056	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26803839	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8674000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	195000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	37000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	417000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-8025000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3628000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	162000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	113000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2262000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-5615000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	417000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2262000	usd
CY2024Q1	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	1573000	usd
CY2023Q1	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	0	usd
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	108000	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	66000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	259000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	116000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	195000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	162000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	87000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	169000	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	117000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	22000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	90000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	123000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-153000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	351000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	448000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-305000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-474000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-18000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-10000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1505000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	363000	usd
CY2024Q1	wdq	Increase Decrease In Social Security Tax Employer Deferral Cares Act IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct	0	usd
CY2023Q1	wdq	Increase Decrease In Social Security Tax Employer Deferral Cares Act IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct	-1442000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	39000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-126000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-28000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1878000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	379000	usd
CY2024Q1	wdq	Origination Of Notes Receivable OriginationOfNotesReceivable	0	usd
CY2023Q1	wdq	Origination Of Notes Receivable OriginationOfNotesReceivable	3000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	59000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-59000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12000	usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	6400000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2895000	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1457000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	1600000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	730000	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	540000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	561000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	113000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3274000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1344000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1337000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-977000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	331000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3546000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1668000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2569000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	589000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	132000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	37000	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2024Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	319000	usd
CY2023Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2781000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q1	wdq	Number Of Subsidiaries NumberOfSubsidiaries	1	subsidiary
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36100000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1900000	usd
CY2024Q1	wdq	Working Capital WorkingCapital	-1400000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1700000	usd
CY2022Q2	wdq	Financing Receivable Before Allowance For Credit Loss Noncurrent Interest Rate FinancingReceivableBeforeAllowanceForCreditLossNoncurrentInterestRate	0.05
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Certain accounting policies involve a “critical accounting estimate” because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. In addition, while we have used our best estimates based on facts and circumstances available to us at the time, different acceptable assumptions would yield different results. Changes in the accounting estimates are reasonably likely to occur from period to period, which may have a material impact on the presentation of our financial condition and results of operations. We review these estimates and assumptions periodically and reflect the effects of revisions in the period that they are determined to be necessary. We believe that the assumptions and estimates associated with income taxes, equity-based compensation (including issuance of common stock for services rendered), and allowance for credit losses have the greatest potential impact on our consolidated financial statements. Therefore, we consider the policies related to these financial areas to be our critical accounting policies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accounting estimates used in the preparation of these financial statements change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. Actual results may differ materially from these estimates.</span></div>
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject us to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with high credit-quality financial institutions. Such deposits may be in excess of federally insured limits. To date, we have not experienced any losses on our cash and cash equivalents. We perform periodic evaluations of the relative credit standing of the financial institutions. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We perform ongoing credit evaluations of our customers’ financial condition and require no collateral from our customers. We maintain a credit loss reserve for expected credit losses based upon the expected collectability of accounts receivable balances. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Effective Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> within this Note below for further information.</span></div>
CY2024Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1300000	usd
CY2024Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	4005000	usd
CY2023Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	3690000	usd
CY2024Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	854000	usd
CY2023Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	853000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4859000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4543000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1648000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1595000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3211000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2948000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	87000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	169000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1595000	usd
CY2024Q1	wdq	Accounts Receivable Credit Loss Expense Reversal Current AccountsReceivableCreditLossExpenseReversalCurrent	53000	usd
CY2024Q1	wdq	Accounts Receivable Allowance For Credit Loss Writeoff Current AccountsReceivableAllowanceForCreditLossWriteoffCurrent	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1648000	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	109000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	379000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	390000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	425000	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	89000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	89000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	588000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	893000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1107000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1048000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	782000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	728000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	325000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	320000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	66000	usd
CY2023Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	0	usd
CY2022Q2	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	250000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	270000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	393000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	95000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	176000	usd
CY2024Q1	wdq	Deferred Financial Advisory Fees Current DeferredFinancialAdvisoryFeesCurrent	1000000	usd
CY2023Q4	wdq	Deferred Financial Advisory Fees Current DeferredFinancialAdvisoryFeesCurrent	1000000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	402000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	382000	usd
CY2024Q1	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	1767000	usd
CY2023Q4	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	1951000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	8000000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	802000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	7198000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	0	usd
CY2023	wdq	Contract With Customer Assets Expense Deferred Including Opening Balance ContractWithCustomerAssetsExpenseDeferredIncludingOpeningBalance	165000	usd
CY2024Q1	wdq	Contract With Customer Assets Amounts Expensed During The Year ContractWithCustomerAssetsAmountsExpensedDuringTheYear	54000	usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2900000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-153000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6474000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7157000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6474000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7157000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	255000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	273000	usd
CY2023Q4	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	273000	usd
CY2022Q4	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	333000	usd
CY2024Q1	wdq	Contract With Customer Assets Expense Deferred Including Opening Balance ContractWithCustomerAssetsExpenseDeferredIncludingOpeningBalance	36000	usd
CY2023	wdq	Contract With Customer Assets Amounts Expensed During The Year ContractWithCustomerAssetsAmountsExpensedDuringTheYear	225000	usd
CY2024Q1	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	255000	usd
CY2023Q4	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	273000	usd
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1525175	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.05
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2271894	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.57
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2244102	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y9M21D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.56
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2964	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.26
CY2024Q1	wdq	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriod	0	shares
CY2024Q1	wdq	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2268930	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.57
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2255034	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M25D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.57
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2255034	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	17000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P98M
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	329000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	329000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	99000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2815000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2815000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	225000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3031000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	340000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3144000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3144000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	324000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	160000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	133000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	160000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	133000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	31000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	126000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2781000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0905
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0567
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	434000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	595000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	592000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	504000	usd
CY2024Q1	wdq	Lessee Operating Lease Liability To Be Paid After Year Three LesseeOperatingLeaseLiabilityToBePaidAfterYearThree	2278000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4403000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1259000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3144000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3144000	usd
CY2023Q1	wdq	Proceeds From Social Security Tax Employer Deferral Cares Act ProceedsFromSocialSecurityTaxEmployerDeferralCARESAct	2000000	usd
CY2023Q1	wdq	Operating Expenses Offset Social Security Tax Employer Deferral Cares Act OperatingExpensesOffsetSocialSecurityTaxEmployerDeferralCARESAct	600000	usd
CY2023Q1	wdq	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	1400000	usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	6000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	3000	usd
CY2022Q2	wdq	Sponsor Escrow Agreement Sponsor Earnout Shares SponsorEscrowAgreementSponsorEarnoutShares	1000000	shares
CY2022Q2	wdq	Sponsor Escrow Agreement Release Of Shares Stock Price Trigger SponsorEscrowAgreementReleaseOfSharesStockPriceTrigger	12.00
CY2022Q2	wdq	Sponsor Escrow Agreement Stock Price Trigger Threshold Trading Days SponsorEscrowAgreementStockPriceTriggerThresholdTradingDays	20	day
CY2022Q2	wdq	Sponsor Escrow Agreement Stock Price Trigger Threshold Trading Day Period SponsorEscrowAgreementStockPriceTriggerThresholdTradingDayPeriod	30	day
CY2022Q2	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	350000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45594864	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45594864	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26940841	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26940841	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	417000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2262000	usd
CY2024Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	85000	usd
CY2023Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	502000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2262000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45432272	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26803839	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	31882784	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77315056	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26803839	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2024Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	96000	usd
CY2023Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	158000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-023235-index-headers.html	Edgar Link	pending
0001628280-24-023235-index.html	Edgar Link	pending
0001628280-24-023235.txt	Edgar Link	pending
0001628280-24-023235-xbrl.zip	Edgar Link	pending
exhibit311ceo906certificat.htm	Edgar Link	pending
exhibit312cfo906certificat.htm	Edgar Link	pending
exhibit321-ceo302certifica.htm	Edgar Link	pending
exhibit322-cfo302certifica.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wdq-20240331.htm	Edgar Link	pending
wdq-20240331.xsd	Edgar Link	pending
wdq-20240331_pre.xml	Edgar Link	unprocessable
wdq-20240331_lab.xml	Edgar Link	unprocessable
wdq-20240331_htm.xml	Edgar Link	completed
wdq-20240331_def.xml	Edgar Link	unprocessable
wdq-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBIG
springbig Holdings Inc Stock $sbig

2024 Q2 Form 10-Q Financial Statement

#000162828024023235 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBIG springbig Holdings Inc Stock $sbig

2024 Q2 Form 10-Q Financial Statement

#000162828024023235 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBIG
springbig Holdings Inc Stock $sbig